PubMed:31992262 JSONTXT

Annnotations TAB JSON ListView MergeView

    sonoma2

    {"project":"sonoma2","denotations":[{"id":"T0","span":{"begin":60,"end":65},"obj":"GENE"},{"id":"T1","span":{"begin":66,"end":80},"obj":"VAR"},{"id":"T2","span":{"begin":84,"end":104},"obj":"DISEASE"},{"id":"T3","span":{"begin":134,"end":164},"obj":"GENE"},{"id":"T4","span":{"begin":135,"end":145},"obj":"GENE"},{"id":"T5","span":{"begin":151,"end":165},"obj":"GENE"},{"id":"T6","span":{"begin":166,"end":171},"obj":"GENE"},{"id":"T7","span":{"begin":167,"end":172},"obj":"GENE"},{"id":"T8","span":{"begin":191,"end":199},"obj":"REG"},{"id":"T9","span":{"begin":210,"end":220},"obj":"DISEASE"},{"id":"T10","span":{"begin":211,"end":221},"obj":"DISEASE"},{"id":"T11","span":{"begin":225,"end":245},"obj":"DISEASE"},{"id":"T12","span":{"begin":226,"end":246},"obj":"DISEASE"},{"id":"T13","span":{"begin":247,"end":250},"obj":"DISEASE"},{"id":"T14","span":{"begin":248,"end":251},"obj":"DISEASE"},{"id":"T15","span":{"begin":286,"end":291},"obj":"GENE"},{"id":"T16","span":{"begin":287,"end":292},"obj":"GENE"},{"id":"T17","span":{"begin":293,"end":307},"obj":"VAR"},{"id":"T18","span":{"begin":356,"end":359},"obj":"DISEASE"},{"id":"T19","span":{"begin":358,"end":361},"obj":"DISEASE"},{"id":"T20","span":{"begin":484,"end":495},"obj":"REG"},{"id":"T21","span":{"begin":502,"end":507},"obj":"GENE"},{"id":"T22","span":{"begin":504,"end":509},"obj":"GENE"},{"id":"T23","span":{"begin":510,"end":524},"obj":"VAR"},{"id":"T24","span":{"begin":529,"end":538},"obj":"CPA"},{"id":"T25","span":{"begin":540,"end":543},"obj":"DISEASE"},{"id":"T26","span":{"begin":542,"end":545},"obj":"DISEASE"},{"id":"T27","span":{"begin":606,"end":617},"obj":"REG"},{"id":"T28","span":{"begin":619,"end":624},"obj":"GENE"},{"id":"T29","span":{"begin":621,"end":626},"obj":"GENE"},{"id":"T30","span":{"begin":627,"end":641},"obj":"VAR"},{"id":"T31","span":{"begin":740,"end":745},"obj":"GENE"},{"id":"T32","span":{"begin":743,"end":748},"obj":"GENE"},{"id":"T33","span":{"begin":782,"end":790},"obj":"REG"},{"id":"T34","span":{"begin":791,"end":794},"obj":"DISEASE"},{"id":"T35","span":{"begin":794,"end":797},"obj":"DISEASE"},{"id":"T36","span":{"begin":866,"end":875},"obj":"REG"},{"id":"T37","span":{"begin":878,"end":883},"obj":"GENE"},{"id":"T38","span":{"begin":881,"end":886},"obj":"GENE"},{"id":"T39","span":{"begin":887,"end":901},"obj":"VAR"},{"id":"T40","span":{"begin":906,"end":916},"obj":"REG"},{"id":"T41","span":{"begin":922,"end":926},"obj":"NEGREG"},{"id":"T42","span":{"begin":927,"end":936},"obj":"CPA"},{"id":"T43","span":{"begin":966,"end":981},"obj":"DISEASE"},{"id":"T44","span":{"begin":986,"end":991},"obj":"DISEASE"},{"id":"T45","span":{"begin":1115,"end":1120},"obj":"GENE"},{"id":"T46","span":{"begin":1118,"end":1123},"obj":"GENE"},{"id":"T47","span":{"begin":1124,"end":1138},"obj":"VAR"},{"id":"T48","span":{"begin":1143,"end":1153},"obj":"REG"},{"id":"T49","span":{"begin":1159,"end":1169},"obj":"CPA"},{"id":"T50","span":{"begin":1171,"end":1177},"obj":"POSREG"},{"id":"T51","span":{"begin":1246,"end":1266},"obj":"CPA"},{"id":"T52","span":{"begin":1320,"end":1325},"obj":"GENE"},{"id":"T53","span":{"begin":1324,"end":1329},"obj":"GENE"},{"id":"T54","span":{"begin":1330,"end":1340},"obj":"MPA"},{"id":"T55","span":{"begin":1349,"end":1359},"obj":"REG"},{"id":"T56","span":{"begin":1365,"end":1374},"obj":"CPA"},{"id":"T57","span":{"begin":1374,"end":1377},"obj":"DISEASE"},{"id":"T58","span":{"begin":1378,"end":1381},"obj":"DISEASE"},{"id":"T59","span":{"begin":1390,"end":1400},"obj":"REG"},{"id":"T60","span":{"begin":1406,"end":1415},"obj":"CPA"},{"id":"T61","span":{"begin":1419,"end":1424},"obj":"DISEASE"}],"relations":[{"id":"R38","pred":"ThemeOf","subj":"T44","obj":"T36"},{"id":"R39","pred":"ThemeOf","subj":"T44","obj":"T40"},{"id":"R40","pred":"ThemeOf","subj":"T44","obj":"T41"},{"id":"R41","pred":"ThemeOf","subj":"T44","obj":"T42"},{"id":"R0","pred":"ThemeOf","subj":"T0","obj":"T1"},{"id":"R1","pred":"ThemeOf","subj":"T2","obj":"T1"},{"id":"R2","pred":"ThemeOf","subj":"T4","obj":"T8"},{"id":"R3","pred":"ThemeOf","subj":"T5","obj":"T8"},{"id":"R4","pred":"ThemeOf","subj":"T7","obj":"T8"},{"id":"R5","pred":"ThemeOf","subj":"T7","obj":"T17"},{"id":"R6","pred":"ThemeOf","subj":"T10","obj":"T8"},{"id":"R7","pred":"ThemeOf","subj":"T12","obj":"T8"},{"id":"R8","pred":"ThemeOf","subj":"T12","obj":"T10"},{"id":"R9","pred":"ThemeOf","subj":"T14","obj":"T8"},{"id":"R10","pred":"ThemeOf","subj":"T14","obj":"T10"},{"id":"R11","pred":"ThemeOf","subj":"T14","obj":"T17"},{"id":"R12","pred":"ThemeOf","subj":"T16","obj":"T8"},{"id":"R13","pred":"ThemeOf","subj":"T16","obj":"T10"},{"id":"R14","pred":"ThemeOf","subj":"T16","obj":"T17"},{"id":"R15","pred":"ThemeOf","subj":"T22","obj":"T20"},{"id":"R16","pred":"ThemeOf","subj":"T22","obj":"T23"},{"id":"R17","pred":"ThemeOf","subj":"T23","obj":"T20"},{"id":"R18","pred":"ThemeOf","subj":"T24","obj":"T20"},{"id":"R19","pred":"ThemeOf","subj":"T24","obj":"T23"},{"id":"R20","pred":"ThemeOf","subj":"T26","obj":"T24"},{"id":"R21","pred":"ThemeOf","subj":"T24","obj":"T27"},{"id":"R22","pred":"ThemeOf","subj":"T26","obj":"T20"},{"id":"R23","pred":"ThemeOf","subj":"T26","obj":"T23"},{"id":"R24","pred":"ThemeOf","subj":"T26","obj":"T27"},{"id":"R25","pred":"ThemeOf","subj":"T30","obj":"T27"},{"id":"R26","pred":"ThemeOf","subj":"T29","obj":"T23"},{"id":"R27","pred":"ThemeOf","subj":"T29","obj":"T27"},{"id":"R28","pred":"ThemeOf","subj":"T29","obj":"T30"},{"id":"R29","pred":"ThemeOf","subj":"T35","obj":"T33"},{"id":"R30","pred":"ThemeOf","subj":"T38","obj":"T36"},{"id":"R31","pred":"ThemeOf","subj":"T38","obj":"T39"},{"id":"R32","pred":"CauseOf","subj":"T39","obj":"T36"},{"id":"R33","pred":"CauseOf","subj":"T39","obj":"T40"},{"id":"R34","pred":"CauseOf","subj":"T39","obj":"T41"},{"id":"R35","pred":"ThemeOf","subj":"T42","obj":"T41"},{"id":"R36","pred":"ThemeOf","subj":"T42","obj":"T36"},{"id":"R37","pred":"ThemeOf","subj":"T42","obj":"T40"},{"id":"R42","pred":"ThemeOf","subj":"T46","obj":"T47"},{"id":"R43","pred":"CauseOf","subj":"T47","obj":"T48"},{"id":"R44","pred":"CauseOf","subj":"T47","obj":"T49"},{"id":"R45","pred":"CauseOf","subj":"T47","obj":"T50"},{"id":"R46","pred":"ThemeOf","subj":"T49","obj":"T48"},{"id":"R47","pred":"ThemeOf","subj":"T51","obj":"T48"},{"id":"R48","pred":"ThemeOf","subj":"T53","obj":"T54"},{"id":"R49","pred":"ThemeOf","subj":"T54","obj":"T55"},{"id":"R50","pred":"ThemeOf","subj":"T54","obj":"T59"},{"id":"R51","pred":"ThemeOf","subj":"T56","obj":"T55"},{"id":"R52","pred":"ThemeOf","subj":"T56","obj":"T59"},{"id":"R53","pred":"ThemeOf","subj":"T58","obj":"T55"},{"id":"R54","pred":"ThemeOf","subj":"T58","obj":"T56"},{"id":"R55","pred":"ThemeOf","subj":"T58","obj":"T59"},{"id":"R56","pred":"ThemeOf","subj":"T60","obj":"T55"},{"id":"R57","pred":"ThemeOf","subj":"T60","obj":"T59"},{"id":"R58","pred":"ThemeOf","subj":"T61","obj":"T60"},{"id":"R59","pred":"ThemeOf","subj":"T61","obj":"T55"},{"id":"R60","pred":"ThemeOf","subj":"T61","obj":"T56"},{"id":"R61","pred":"ThemeOf","subj":"T61","obj":"T59"}],"text":"Prognostic value and clinicopathological characteristics of PD-L1 overexpression in non-Hodgkin lymphoma: a meta-analysis.\nBACKGROUND: Programmed cell death ligand 1 (PD-L1) has already been detected in various carcinomas. In non-Hodgkin lymphoma (NHL), however, the prognostic value of PD-L1 overexpression remains unclear.\nMETHODS: A meta-analysis of 2321 NHL patients from 12 studies was performed. Hazard ratios (HRs) with 95% confidence intervals (CIs) were used to evaluate the correlation between PD-L1 overexpression and prognosis of NHL, and odds ratios (ORs) with 95% CIs were used to assess the association of PD-L1 overexpression with clinicopathological factors.\nRESULTS: The results showed that no significant difference between PD-L1 positive and negative groups was detected in NHL (HR: 1.40, 95% CI: 0.90-2.19; P = 0.137). Nevertheless, the results indicated that PD-L1 overexpression was associated with poor prognosis in the subtype of diffuse large B cell lymphoma (DLBCL) (HR: 1.70, 95% CI: 1.05-2.74; P = 0.031). We also performed subgroup analyses and meta-regression. The pooled OR showed that PD-L1 overexpression was associated with B symptoms, higher international prognostic index (IPI) score (3, 4, and 5 points) and Ann Arbor Stages III and IV.\nCONCLUSIONS: The meta-analysis demonstrated that PD-L1 expression was not associated with prognosis of NHL but was associated with prognosis of DLBCL."}